Detailansicht

Wissensnetz

Person

Stefanie Hahner (1974-)

Internistin

Name	Stefanie Hahner
Zeit	1974- (Lebensdaten)
Ort	Kassel (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Internistin (charakteristischer Beruf)
Variante	Stephanie Hahner
Weitere Angaben	Diss. Medizinische Fakultät an der Universität Würzburg (2003); Habil.-Schr. Medizinische Fakultät (Fach Innere Medizin) an der Universität Würzburg (2010)
Datensatztyp	Person
GND-Nummer	124498299
Datensatz-ID	124498299
Beteiligt an alle anzeigen Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors — a comprehensive analysis of imaging findings and comparison with histopathology CXCR4-targeted theranostics in oncology Radiopharmaceuticals for treatment of adrenocortical carcinoma CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology Adrenal Crisis �� Definition, Prevention and Treatment: Results from a Delphi Survey CXCR4-targeted theranostics in oncology Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT Imaging of C-X-C motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-Pentixafor PET Impact of tumor burden on normal organ distribution in patients imaged with CXCR4-targeted [68Ga]Ga-PentixaFor PET/CT Novel CYP11B-ligand [\(^{123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography A theranostic approach for adrenocortical neoplasia based on high adrenal CXCR4 expression [Abstract] Selektive Aldosteronsynthaseinhibitoren in der funktionellen Bildgebung zur Differenzialdiagnose des Primären Hyperaldosteronismus - Entwicklung eines Testsystems und Evaluation geeigneter Substanzen Von adrenaler Insuffizienz zur molekularen Bildgebung : neue diagnostische und therapeutische Strategien bei Nebennierenerkrankungen The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease Wirkung von Etomidat auf zelluläre Regulationsmechanismen der Nebennierenrinde Wirkung von Etomidat auf zelluläre Regulationsmechanismen der Nebennierenrinde

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Stefanie Hahner (1974-)

Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma

Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors — a comprehensive analysis of imaging findings and comparison with histopathology

CXCR4-targeted theranostics in oncology

Radiopharmaceuticals for treatment of adrenocortical carcinoma

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology

Adrenal Crisis ��� Definition, Prevention and Treatment: Results from a Delphi Survey

CXCR4-targeted theranostics in oncology

Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT

Imaging of C-X-C motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-Pentixafor PET

Impact of tumor burden on normal organ distribution in patients imaged with CXCR4-targeted [68Ga]Ga-PentixaFor PET/CT

Novel CYP11B-ligand [\(^{123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience

Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma

Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry

Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients

Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography

Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide

Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography

A theranostic approach for adrenocortical neoplasia based on high adrenal CXCR4 expression [Abstract]

Selektive Aldosteronsynthaseinhibitoren in der funktionellen Bildgebung zur Differenzialdiagnose des Primären Hyperaldosteronismus - Entwicklung eines Testsystems und Evaluation geeigneter Substanzen

Von adrenaler Insuffizienz zur molekularen Bildgebung : neue diagnostische und therapeutische Strategien bei Nebennierenerkrankungen

The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease

Wirkung von Etomidat auf zelluläre Regulationsmechanismen der Nebennierenrinde

Wirkung von Etomidat auf zelluläre Regulationsmechanismen der Nebennierenrinde

Adrenal Crisis �� Definition, Prevention and Treatment: Results from a Delphi Survey